"Why do some patients stay in remission, while others see their cancer return?
To get a better idea of who will be more likely to relapse, researchers are trying to understand a process whose rules are constantly being written and rewrit"...
None.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/30/2015
Additional Zelboraf Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.